Cover Picture: 2‐Phenoxy‐nicotinamides are Potent Agonists at the Bile Acid Receptor GPBAR1 (TGR5) (ChemMedChem 4/2013)

Abstract

Graphical Abstract The front cover picture shows a 3D homology model of the human G protein-coupled bile acid receptor (GPBAR1; carbon atoms in green). The full receptor structure is shown (top right) with the proposed binding site of GPBAR1 agonists indicated (red ellipse). The main picture shows a zoom of this binding site into which taurolithocholic acid (TLCA; carbon atoms in cyan) and a 2-phenoxy-nicotinamide agonist (carbon atoms in magenta) are docked. The alignment of TLCA with our advanced lead compounds enabled the identification of the optimal attachment point for a polar vector, which was critical to improve the physicochemical properties of the series. For more details, see the Communication by Rainer E. Martin et al. on p. 569 ff.

Related Papers

• → Bile acid metabolism and signaling in liver disease and therapy(2017)288 cited
• → Developments in bile salt based therapies: A critical overview(2018)77 cited
• → Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes(2007)71 cited
• → Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction(2021)48 cited
• → TGR5 signaling mitigates parenteral nutrition-associated liver disease(2020)20 cited